No More Rate Hikes! Here’s Why I’m Buying Cineplex Stock

The pause on rate hikes should inspire investors to consider Cineplex Inc. (TSX:CGX) stock, as the cinema has stormed back.

| More on:
man is enthralled with a movie in a theater

Source: Getty Images

On Wednesday, April 12, the Bank of Canada (BoC) announced that it would hold the benchmark interest rate at 4.5%. That has been the benchmark rate since January 2022. BoC governor Tiff Macklem maintained that the central bank would stay the course with its restrictive monetary policy, as risks to the economy remained present.

Today, I want to discuss why I’m looking to snatch up a stock like Cineplex (TSX:CGX) in this interest rate environment. Let’s jump in.

What does a rate-hike pause mean for investors right now?

The pause on interest rate hikes may give investors and consumers alike some time to regroup after a period of extremely aggressive hikes in 2022. Canadian stocks were broadly hit by volatility in the spring of 2022, and the S&P/TSX Composite Index has still failed to reclaim its March 2022 highs.

In my recent pieces, I’d discussed the industries that could benefit in a high interest rate environment. Bank stocks have been hit by volatility in this market. However, Canada’s top banks have benefited from improved profit margins due to interest rate hikes. That means investors should not see this as a time to stray from Canada’s profit machines.

What has spurred me to look at Cineplex in this climate? Consumer discretionary stocks can also perform well in the face of higher interest rates on the back of higher employment. Moreover, we should not underestimate the recent successes that have populated the cinema.

Here’s why the cinema industry may be on the comeback trail…

This year has seen three films break through the $200 million domestic mark so far. Ant-Man and the Wasp: Quantumania raked in $212 million domestically following a February 17th release. Meanwhile, Avatar: The Way of Water continued its impressive momentum after its December 2022 release and gobbled up $282 million domestically so far in 2023. However, The Super Mario Bros. Movie has blown past expectations for Universal Pictures. The movie based on the long-standing video game series has generated $358 million at the domestic box office so far after an April 5th release date. It is well on its way to a global gross that should exceed $1 billion.

There are some promising movies on deck for Cineplex and its peers, as we look ahead to the spring and summer blockbuster seasons in 2023. Movies like Guardians of the Galaxy: Vol 3, the live action adaptation of The Little Mermaid, Indiana Jones and the Dial of Destiny, and the Barbie movie all hold tremendous potential to deliver big on the domestic box office in the months ahead.

In fiscal 2022, Cineplex achieved total revenue growth of 93% to $1.26 billion. Meanwhile, box office and concession revenues per patron climbed 3% and 10%, respectively, compared to the previous year. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) surged 320% to $251 million for fiscal 2022.

Cineplex: Why I’m Buying this stock in April

Shares of Cineplex have jumped 14% month over month as of close on April 18. The stock is now up 11% in the year-to-date period. However, shares of Cineplex are still down 34% year over year.

Cineplex is facing challenges ahead, but it is on track for solid revenue growth going forward. Moreover, it has climbed back to profitability and is trading in favourable value territory compared to its industry peers. I like Cineplex as a contrarian pick in the current climate.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool recommends Cineplex. The Motley Fool has a disclosure policy.

More on Investing

Canada national flag waving in wind on clear day
Tech Stocks

Trump Trade: Canadian Stocks to Watch

With Trump returning to the presidency, there are some sectors that could boom in Canada, and others to watch. But…

Read more »

A train passes Morant's curve in Banff National Park in the Canadian Rockies.
Investing

Is Canadian National Railway Worth Buying for its 2.2% Dividend Yield?

Let's dive into whether Canadian National Railway (TSX:CNR) is a top buy for long-term investors at this point in the…

Read more »

nuclear power plant
Energy Stocks

Is Cameco Stock Still a Buy?

Cameco stock recently reported earnings that showed the Westinghouse investment is creating some major costs. But that could change.

Read more »

cloud computing
Dividend Stocks

Insurance Showdown: Better Buy, Great-West Life or Manulife Stock?

GWO stock and MFC stock are two of the top names in insurance, but which holds the better outlook?

Read more »

analyze data
Dividend Stocks

Here’s Why the Average TFSA for Canadians Aged 41 Isn’t Enough

The average TFSA simply isn't enough for most Canadians in their early 40s. Here's how to catch up.

Read more »

A plant grows from coins.
Dividend Stocks

The Smartest Dividend-Growth Stocks to Buy With $1,000 Right Now

New dividend-growth investors should consider CN Rail (TSX:CNR) stock and another top play if they're looking to build wealth over…

Read more »

concept of real estate evaluation
Dividend Stocks

How to Earn a TFSA Paycheque Every Month and Pay No Taxes on It

Canadian REITs can turn your TFSA into a monthly paycheque machine for life. Here's how Morguard North American Residential REIT…

Read more »

Start line on the highway
Investing

2 No-Brainer Growth Stocks to Buy Now With $5,000 and Hold Long Term

Market conditions today are ideal for growth investing, and two rising stocks are no-brainer buys in November.

Read more »